Coccidioidomycosis: Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Bhima Shankar , Pulmonologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Coccidioidomycosis, also known as Valley fever, is a fungal infection caused by inhaling spores of Coccidioides fungi found in dry, dusty soil. It primarily affects the lungs but can spread to the skin, bones, joints, or brain in severe cases. Common symptoms include fever, cough, chest pain, fatigue, and shortness of breath, although some people may have no symptoms.

The condition is more common in people living in or traveling to certain desert regions and in those with weakened immune systems. Early diagnosis and appropriate antifungal treatment can help prevent complications and improve recovery.

What are the Causes of Coccidioidomycosis?

The primary cause of coccidioidomycosis is inhalation of airborne spores of Coccidioides fungi. These spores are released into the air when contaminated soil is disturbed by natural events, such as windstorms, or human activities, like construction. Once inhaled, the spores can settle in the lungs and cause infection.

While anyone exposed to the spores can contract coccidioidomycosis, not everyone will develop symptoms. The immune system plays a crucial role in determining whether the infection will be asymptomatic, mild, or severe.

What are the Symptoms of Coccidioidomycosis?

Initial Symptoms

The initial symptoms of coccidioidomycosis often resemble those of a respiratory infection or flu, making early diagnosis challenging. Common symptoms include:

Fever
Cough
Chest pain
Fatigue
Shortness of breath
Headaches
Night sweats

These symptoms typically develop one to three weeks after exposure to the fungal spores. In many cases, the infection is self-limiting and resolves without medical intervention. However, for some individuals, particularly those with weakened immune systems, the disease can progress.

Severe and Disseminated Symptoms

In severe cases, coccidioidomycosis can lead to chronic pulmonary conditions or disseminated disease, where the infection spreads beyond the lungs to other parts of the body. Symptoms of disseminated coccidioidomycosis may include:

Skin lesions
Bone and joint pain
Meningitis
Swollen lymph nodes

Prompt diagnosis and treatment are essential to prevent severe complications.

When to See a Doctor for Coccidioidomycosis?

Coccidioidomycosis, also known as Valley fever, is a fungal infection that primarily affects the lungs but can sometimes spread to other parts of the body. If you experience persistent respiratory symptoms, fever, or worsening illness after exposure to areas where the fungus is common, consult a Pulmonologist. Early diagnosis and treatment can help prevent complications and support a faster recovery.

If you have a cough lasting more than a few weeks.
If you experience persistent fever, chills, or excessive fatigue.
If you develop chest pain or difficulty breathing.
If you have unexplained weight loss or night sweats.
If your symptoms worsen despite rest or initial treatment.
If you have a weakened immune system, diabetes, or are pregnant and develop symptoms of Valley fever.
If you notice skin rashes, joint pain, or signs that the infection may have spread beyond the lungs.
If you are diagnosed with or suspected to have coccidioidomycosis, consult a Pulmonologist for comprehensive evaluation, appropriate antifungal treatment, and long-term follow-up care.

Find Pulmonologists for Coccidioidomycosis Treatment Near You

How is Coccidioidomycosis Diagnosed?

Diagnosing coccidioidomycosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Healthcare providers may order the following diagnostic tests:

Serologic Tests: These tests detect antibodies against Coccidioides in the blood, indicating an immune response to the fungus.
Culture Tests: Culturing a sample, such as sputum, can confirm the presence of Coccidioides.
Polymerase Chain Reaction (PCR): PCR can detect fungal DNA in clinical specimens, providing a rapid and sensitive diagnostic tool.
Imaging Studies: Chest X-rays or CT scans can reveal lung abnormalities consistent with coccidioidomycosis.

A thorough patient history, including recent travel to endemic areas, is also critical for accurate diagnosis.

How is Coccidioidomycosis Treated?

Mild to Moderate Cases

For individuals with mild to moderate coccidioidomycosis, rest and supportive care are often sufficient. Physicians may recommend over-the-counter pain relievers and cough suppressants to alleviate symptoms. Most healthy individuals recover without the need for antifungal medications.

Severe or Disseminated Cases

In cases where the infection is severe or disseminated, antifungal treatment is necessary. Commonly prescribed antifungal medications include:

Fluconazole: Often the first-line treatment for non-life-threatening coccidioidomycosis.
Itraconazole: An alternative to fluconazole that is commonly used for bone and joint involvement.
Amphotericin B: Reserved for severe, life-threatening infections because of its potential side effects.

Monitoring and Follow-Up

Patients undergoing treatment for coccidioidomycosis require regular monitoring to assess their response to therapy and detect potential complications. Follow-up care is essential to ensure complete recovery and manage any chronic symptoms that may persist.

Your health is everything - prioritize your well-being today.

Consult Coccidioidomycosis Doctors Today

What are the Risk Factors for Coccidioidomycosis?

Several factors can increase the risk of contracting coccidioidomycosis:

Geographic Location: Living in or traveling to endemic regions significantly increases the risk.
Occupational Exposure: Jobs involving soil disturbance, such as construction, farming, or archaeology, increase exposure to fungal spores.
Immune System Status: Individuals with weakened immune systems, including those with HIV/AIDS, undergoing chemotherapy, or taking immunosuppressive medications, are at greater risk of severe disease.
Age and Ethnicity: Older adults and certain ethnic groups, including African Americans and Filipinos, may have a higher risk of developing severe coccidioidomycosis.

Understanding these risk factors can help reduce exposure, promote early diagnosis, and improve disease management.

Frequently Asked Questions

1. What are the symptoms of coccidioidomycosis?

Symptoms may include flu-like symptoms such as fever, cough, chest pain, and fatigue, often presenting within 1 to 3 weeks after exposure to the fungus in endemic areas.

2. What causes coccidioidomycosis?

Coccidioidomycosis is caused by the inhalation of spores from the Coccidioides fungus, which is found in arid regions of the southwestern United States and parts of Central and South America.